We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

placeholder="Enter search term...">
Suitcase

Dengue Fever in Sri Lanka

03 April 2017

A media reportof 1 April 2017, quoting health officials, is advising that there have been 26 000 patients diagnosed with dengue fever over the course of this year. Nearly 50% of the patients were reported from the Western Province. Fifty three individuals have died in the last 90 days.

Advice for Travellers

All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection. Prevention relies on avoiding mosquito bites.

Vaccine

There is no vaccine against dengue fever licensed in the UK.

Dengvaxia®, developed by Sanofi Pasteur MSD, is the first vaccine to be licensed in the world for the prevention of dengue.

    • Mexico, Costa Rica, the Phillipines and Brazil are the first countries to have granted marketing authorization for Dengvaxia®

At present the World Health Organisation (WHO) is trialling several candidate vaccines against dengue fever.